XML 53 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Cash Equivalents, Investments and Strategic Investments (Tables)
 12 Months Ended
Jan. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Schedule of Cash Equivalents and Investments
The following is a summary of the Company’s cash equivalents, short-term investments, and long-term investments on the consolidated balance sheets (in thousands):

January 31, 2026
Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Estimated
Fair Value
Cash equivalents:
Money market funds$1,752,777 $— $— $1,752,777 
Time deposits108,727 — — 108,727 
U.S. government securities94,523 9 — 94,532 
Commercial paper40,384 2 (7)40,379 
Certificates of deposit2,808 — — 2,808 
Corporate notes and bonds75 — — 75 
Total cash equivalents1,999,294 11 (7)1,999,298 
Investments:
Corporate notes and bonds1,382,374 4,473 (11)1,386,836 
U.S. government and agency securities484,453 961 (14)485,400 
Certificates of deposit65,643 46 — 65,689 
Commercial paper18,605 6 — 18,611 
Total investments1,951,075 5,486 (25)1,956,536 
Total cash equivalents and investments$3,950,369 $5,497 $(32)$3,955,834 
January 31, 2025
Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Estimated
Fair Value
Cash equivalents:
Money market funds$1,741,089 $— $— $1,741,089 
U.S. government securities388,578 92 — 388,670 
Time deposits113,851 — — 113,851 
Corporate notes and bonds4,466 — — 4,466 
Commercial paper3,064 — — 3,064 
Total cash equivalents
2,251,048 92 — 2,251,140 
Investments:
Corporate notes and bonds1,559,893 2,177 (1,520)1,560,550 
U.S. government and agency securities609,937 528 (727)609,738 
Commercial paper307,752 142 (38)307,856 
Certificates of deposit187,112 97 (4)187,205 
Total investments2,664,694 2,944 (2,289)2,665,349 
Total cash equivalents and investments
$4,915,742 $3,036 $(2,289)$4,916,489 
Schedule of Cash Equivalents and Investments
The following is a summary of the Company’s cash equivalents, short-term investments, and long-term investments on the consolidated balance sheets (in thousands):

January 31, 2026
Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Estimated
Fair Value
Cash equivalents:
Money market funds$1,752,777 $— $— $1,752,777 
Time deposits108,727 — — 108,727 
U.S. government securities94,523 9 — 94,532 
Commercial paper40,384 2 (7)40,379 
Certificates of deposit2,808 — — 2,808 
Corporate notes and bonds75 — — 75 
Total cash equivalents1,999,294 11 (7)1,999,298 
Investments:
Corporate notes and bonds1,382,374 4,473 (11)1,386,836 
U.S. government and agency securities484,453 961 (14)485,400 
Certificates of deposit65,643 46 — 65,689 
Commercial paper18,605 6 — 18,611 
Total investments1,951,075 5,486 (25)1,956,536 
Total cash equivalents and investments$3,950,369 $5,497 $(32)$3,955,834 
January 31, 2025
Amortized
Cost		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Estimated
Fair Value
Cash equivalents:
Money market funds$1,741,089 $— $— $1,741,089 
U.S. government securities388,578 92 — 388,670 
Time deposits113,851 — — 113,851 
Corporate notes and bonds4,466 — — 4,466 
Commercial paper3,064 — — 3,064 
Total cash equivalents
2,251,048 92 — 2,251,140 
Investments:
Corporate notes and bonds1,559,893 2,177 (1,520)1,560,550 
U.S. government and agency securities609,937 528 (727)609,738 
Commercial paper307,752 142 (38)307,856 
Certificates of deposit187,112 97 (4)187,205 
Total investments2,664,694 2,944 (2,289)2,665,349 
Total cash equivalents and investments
$4,915,742 $3,036 $(2,289)$4,916,489 
Schedule of Available For Sale Securities Remaining Contractual Maturity The estimated fair values of available-for-sale marketable debt securities, classified as short-term or long-term investments on the Company’s consolidated balance sheets, by remaining contractual maturity, are as follows (in thousands):
January 31, 2026
Estimated
Fair Value
Due within 1 year$1,201,523 
Due in 1 year to 3 years
755,013 
Total$1,956,536 
Schedule of Fair Value Measurements
The following table presents the Company’s strategic investments by type (in thousands):

January 31, 2026
January 31, 2025
Equity securities:
Non-marketable equity securities under Measurement Alternative$359,114 $281,158 
Non-marketable equity securities under equity method5,241 5,491 
Marketable equity securities6,264 13,833 
Debt securities:
Non-marketable debt securities10,000 750 
Total strategic investments—included in other assets$380,619 $301,232 
Realized and Unrealized Gain (Loss) on Investments
The following table summarizes the gains and losses associated with the Company’s strategic investments in equity securities (in thousands):

Fiscal Year Ended January 31,
202620252024
Unrealized losses on non-marketable equity securities under Measurement Alternative:
Impairments$(53,852)$(11,578)$(3,101)
Net unrealized gains (losses) on marketable equity securities
(7,569)(2,428)15,197 
Net unrealized gains (losses) on strategic investments in equity securities
(61,421)(14,006)12,096 
Net realized gains (losses) on strategic investments in equity securities(1)
1,526 (17,414)34,713 
Total—included in other income (expense), net
$(59,895)$(31,420)$46,809 
________________
(1)The net realized gains on strategic investments in equity securities for the fiscal year ended January 31, 2024 include primarily a remeasurement gain of $34.0 million recognized on a previously held equity interest as a result of a business combination completed during fiscal 2024. See Note 7, “Business Combinations,” for further details. For strategic investments in equity securities sold, the realized gains or losses represent the difference between the sale proceeds and the carrying value of the securities at the beginning of the period or the purchase date, if later